Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-02-25 @ 5:49 PM
Study NCT ID:
NCT02852967
Status:
COMPLETED
Last Update Posted:
2022-03-16
First Post:
2016-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
Sponsor:
Kadmon Corporation, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-29
First Submit QC Date:
None
Study First Post Date:
2016-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-13
Results First Submit QC Date:
None
Results First Post Date:
2021-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-04-24
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-03-07
Last Update Post Date:
2022-03-16
Last Update Post Date Type:
ACTUAL